AiCuris

About:

AiCuris is a pharmaceutical company that discovers, researches and develops antiviral and antibacterial agents to treat infectious diseases.

Website: http://www.aicuris.com

Twitter/X: aicuris

Description:

AiCuris is a clinical-stage biopharmaceutical company focused on resistance breaking antiviral and antibacterial therapeutics targeting Human Cytomegalovirus, Herpes simplex, HIV, Hepatitis B and C and multi-resistant bacteria. AiCuris‘ mission is the development of innovative drugs against severe and life-threatening infectious diseases with high medical need. AiCuris aims to be THE successful innovator for antiviral and antibacterial therapy.

Total Funding Amount:

$74.8M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Wuppertal, Nordrhein-Westfalen, Germany

Founded Date:

2006-01-01

Contact Email:

info(AT)aicuris.com

Founders:

Helga Rübsamen-Schaeff

Number of Employees:

51-100

Last Funding Date:

2010-04-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai